Found 12 results
Author Title [ Type(Desc)] Year
Filters: Author is Oden, NL  [Clear All Filters]
Conference Paper
B. A. Blodi, Ip, M. S., Scott, I. U., Oden, N. L., Van Veldhuisen, P. C., and Warren, K., Clinical vs. Reading Center Baseline Evaluation of Dense Retinal Hemorrhage in the SCORE Branch Retinal Vein Occlusion (BRVO) Study, in Macula Society Annual Meeting, Palm Beach, FL, 2008.
N. L. Oden, Lilienfeld, D., and Ederer, F., Sensitivity with Specificity of a Screening Questionnaire for Dry Eye, in Second International Conference on the Lacrimose Gland, Tear Film and Dry Eye Syndromes: Basic Social and Clinical Relevance, 1996.
Journal Article
C. H. Cole, Oden, N. L., Lindblad, A. S., Phelps, D. L., and Palmer, E. A., Abstract CRYO-ROP risk model prediction of retinopathy (RM-ROP) progression from prethreshold (Th) ROP, 2000.
M. P. Bogenschutz, Donovan, D. M., Mandler, R. N., Perl, H. I., Forcehimes, A. A., Crandall, C., Lindblad, R., Oden, N. L., Sharma, G., Metsch, L., Lyons, M. S., McCormack, R., Konstantopoulos, W. M., and Douaihy, A., Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments: A Randomized Clinical Trial, JAMA Intern Med, vol. 174, pp. 1736-1745, 2014.
R. R. Sokol, Oden, N. L., Rosenberg, M. S., and Thomson, B. A., Cancer incidences in Europe related to mortalities, ethnohistoric, genetic, and geographic distances, Proceedings of the National Academy of Science, vol. 97, pp. 6067-72, 2000.
N. L. Oden and Sullivan, E. K., Estimating a Mean for Paired and Unpaired Eye Data, 1996.
P. T. Korthuis, Lum, P. J., Vergara-Rodriguez, P., Ahamad, K., Wood, E., Kunkel, L. E., Oden, N. L., Lindblad, R., Sorensen, J. L., Arenas, V., Ha, D., Mandler, R. N., and McCarty, D., Feasibility and Safety of Extended-Release Naltrexone Treatment of Opioid and Alcohol use Disorder in HIV Clinics: a Pilot/Feasibility Randomized Trial, Addiction, vol. 112, no. 6, pp. 1036-1044, 2017.
N. L. Oden, Lindblad, A. S., and Phelps, D., Interim monitoring in the supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP) study: Design and implementation, 2000.
I. U. Scott, Van Veldhuisen, P. C., Oden, N. L., Ip, M. S., Blodi, B. A., Jumper, J. M., Figueroa, M., and Group, T. S. C. O. R. E. Stud, Score Study Report 1: Baseline Associations Between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion, Ophthalmology, vol. 116, pp. 504-512, 2009.
M. S. Ip, Scott, I. U., Van Veldhuisen, P., Oden, N. L., Blodi, B. A., Fisher, M., Singerman, L. J., Tolentino, M., Chan, C. K., and Gonzalez, V. H., SCORE Study Report 5: A Randomized Trial Comparing the Efficacy & Safety of Intravitreal Triamcinolone with Observation to Treat Vision Loss Associated with Macular Edema Secondary to Central Retinal Vein Occlusion.., Archives of Ophthalmology, vol. 127, no. 9, pp. 1101-1114, 2009.
D. L. Phelps, Oden, N. L., Cole, C., Wood, N. E., Young, T. L., and Brozanski, B. S., Timing of retinopathy of prematurity (ROP) events: screening implications, 2000.